<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="168237">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01994499</url>
  </required_header>
  <id_info>
    <org_study_id>2013/009/HP</org_study_id>
    <nct_id>NCT01994499</nct_id>
  </id_info>
  <brief_title>Randomized Study Comparing Pleural Drainage by Videothoracoscopy to Medical Drainage in Infectious Pleural Effusion</brief_title>
  <acronym>VIDMED</acronym>
  <official_title>Randomized Study Comparing Pleural Drainage by Videothoracoscopy to Medical Drainage in Infectious Pleural Effusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infectious pleural effusion is a classic complication of pneumonia and often require pleural
      drainage.

      There is no consensus between surgical drainage and medical drainage indication in first
      intention to treat an empyema.

      Usually surgery is proposed in second intention after failure of medical drainage.

      Videothoracoscopy is well accepted in diagnosis and treatment of pleural pathologies. The
      morbidity of this approach is very low with good results and become the gold standard in
      different pleural diseases. The medical drainage can be also very efficient but its results
      depends of the evolution of the pleural effusion. The rate of failure is estimated around
      25%.

      Then, the aim of our study is to compare surgical drainage and medical drainage in first
      intention. The first end-point will be the hospital stay (day). Hospital discharge will be
      strict, following different objective criteria  of healing allowing comparison between these
      two approaches of drainage.

      To answer this question we will randomized 50 patients in 2 years with a multicenter
      recruitment.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Hospital Stay in days</measure>
    <time_frame>patients will be followed for the duration of the hopital stay, an expected average of 4 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Infectious Pleural Effusion</condition>
  <arm_group>
    <arm_group_label>videothoracoscopy  drainage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>videothoracoscopy  drainage of pleural effusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medical pleural drainage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Medical drainage</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Videothoracoscopy drainage</intervention_name>
    <description>videothoracoscopy drainage of pleural effusion</description>
    <arm_group_label>videothoracoscopy  drainage</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Medical drainage</intervention_name>
    <description>Medical pleural drainage</description>
    <arm_group_label>Medical pleural drainage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infectious pleural effusion diagnosed by pleural punction with biologic features of
             infection: C Reactive Protein level &gt;5 mg/L, White cells counts &gt; 10000 G/L,
             Temperature &gt;38°c, effusion with a ph&lt;7,2 or presence of polynuclear, and radiologic
             features of effusion requiring drainage (&gt;1/5 thoracic volume)

        Exclusion Criteria:

          -  prior thoracic surgery, past history of pleural effusion

          -  compressive effusion which should be treated in emergency

          -  Pregnancy

          -  No acceptance of the protocol by the informed patient
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>jean-marc baste, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Rouen, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>jean-marc Baste, MD</last_name>
    <phone>232888990</phone>
    <phone_ext>0033</phone_ext>
    <email>jean-marc.baste@chu-rouen.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Amiens</city>
        <zip>80000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>pascal berna, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>gerard Zachmann, Prof</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 19, 2013</lastchanged_date>
  <firstreceived_date>October 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infection</mesh_term>
    <mesh_term>Pleural Effusion</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
